Mariner Wealth Advisors (NYC)’s GSK GSK Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$146K	Buy	+2,526	New	+$145K	0.07%	77

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s GSK Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in GSK (GSK) in Q1 2015: 2,526 shares worth $146K. The stake represents 0.07% of the portfolio and ranks #77 among its holdings.

741 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

Mariner Wealth Advisors (NYC) held 2,526 shares of GSK worth $146K as of Q1 2015.
GSK was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
GSK made up 0.07% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #77 holding.
741 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.